ReviewCellular and molecular life sciences : CMLS2023
Receptor tyrosine kinase inhibitors in cancer.
Nasim Ebrahimi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
70 papers cite itlatest 60 shown
this papercites it
ReviewCellular and molecular life sciences : CMLS2023
Nasim Ebrahimi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.